Article
Roche: Retinale® – EURETINA Kompakt
Lumithera: Photobiomodulation Preclinical Mechanisms to Clinical Application: US Pivotal LIGHTSITE III Trial Results in Intermediate dry AMD Patients
Sei Moon
August 9, 2022
Article
Lumithera: Photobiomodulation Preclinical Mechanisms to Clinical Application: US Pivotal LIGHTSITE III Trial Results in Intermediate dry AMD Patients
Lumithera: Photobiomodulation Preclinical Mechanisms to Clinical Application: US Pivotal LIGHTSITE III Trial Results in Intermediate dry AMD Patients
Sei Moon
August 9, 2022
Article
AbbVie: Evolving Management in Diabetic Macula Edema
AbbVie: Evolving Management in Diabetic Macula Edema
Sei Moon
August 8, 2022
Article
DORC: EVA NEXUS™: The Future of Ophthalmic Surgery
DORC: EVA NEXUS™: The Future of Ophthalmic Surgery
Sei Moon
August 8, 2022
Article
Subspecialty Session: Tumours V: Paediatric Melanoma
Subspecialty Session: Tumours IV
Sei Moon
August 5, 2022
Podcast
Episode 15: Euretina Congress Keynotes
In this episode, Euretina President Mr Alistair Laidlaw previews two of our keynote speakers from this year’s Euretina Congress in Hamburg. He is joined by Professor Sobha Sivaprasad (UK) and Professor Catherine Creuzot-Garcher (France).
Sei Moon
August 1, 2022
YouTube
Educational Debate 6: July Double Debate! (27 Jul, 2022)
Welcome to the 6th Euretina Educational Double Debate, which took place on the 27th of July 2022 covering two hot topics in retina right now.
Sei Moon
July 28, 2022
Article
Heidelberg Engineering GmbH: Heidelberg AppWay: Secure workflow solution for access to ophthalmic applications and AI algorithms
Heidelberg Engineering GmbH: Heidelberg AppWay: Secure workflow solution for access to ophthalmic applications and AI algorithms
EURETINA
July 26, 2022
Article
ZEISS: OCTA-A Innovations: deeper, wider, and beyond Ophthalmology
ZEISS: OCTA-A Innovations: deeper, wider, and beyond Ophthalmology
EURETINA
July 26, 2022
Article
Subspecialty Session: Tumours IV: Uveal Melanoma
Subspecialty Session: Tumours IV
EURETINA
July 25, 2022
Article
Subspecialty Session: Tumours III: Vascular Tumors
Subspecialty Session: Tumours III
EURETINA
July 25, 2022
Article
Subspecialty Session: Tumours II: Masquarading syndromes and lymfoma
Subspecialty Session: Tumours II
EURETINA
July 25, 2022
